Lasola, Emie .
HRN: 11-97-04 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/22/2023
CEFUROXIME 500MG (TAB)
11/22/2023
11/29/2023
PO
500 Mg
BID
S/P NSVD
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes